Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3176
PUT
Amdocs
DOX
$4.61B
| $618K | ﹤0.01% |
10,800
-2,700
| -20% | -$155K |
2026 Q1
2 quarters
|
|
3177
Ovid Therapeutics
OVID
$481M
| $617K | ﹤0.01% |
247,799
+228,862
| +1,209% | +$599K |
2025 Q1
6 quarters
|
|
3178
Perdoceo Education
PRDO
$1.81B
| $617K | ﹤0.01% |
19,933
-106,766
| -84% | -$3.49M |
2024 Q4
7 quarters
|
|
3179
Monopar Therapeutics
MNPR
$488M
| $616K | ﹤0.01% |
+7,738
| New | +$830K |
2026 Q3
0 quarters
|
|
3180
Dorman Products
DORM
$3.89B
| $616K | ﹤0.01% |
5,026
-29,317
| -85% | -$3.88M |
2026 Q1
2 quarters
|
|
3181
Helus Pharma Inc. Common Stock
HELP
$647M
| $615K | ﹤0.01% |
+50,076
| New | +$523K |
2026 Q3
0 quarters
|
|
3182
Anteris Technologies
AVR
$571M
| $614K | ﹤0.01% |
+79,079
| New | +$686K |
2026 Q3
0 quarters
|
|
3183
Agilysys
AGYS
$3.43B
| $614K | ﹤0.01% |
6,327
-4,135
| -40% | -$445K |
2026 Q1
2 quarters
|
|
3184
PUT
Signet Jewelers
SIG
$4.53B
| $614K | ﹤0.01% |
6,000
-1,200
| -17% | -$110K |
2023 Q4
11 quarters
|
|
3185
PPG Industries
PPG
$27B
| $613K | ﹤0.01% |
5,874
-22,903
| -80% | -$2.59M |
2022 Q4
15 quarters
|
|
3186
UP Fintech Holding
TIGR
$705M
| $612K | ﹤0.01% |
133,302
+76,653
| +135% | +$369K |
2024 Q1
10 quarters
|
|
3187
CALL
Mohawk Industries
MHK
$8.52B
| $611K | ﹤0.01% |
+4,900
| New | +$609K |
2026 Q3
0 quarters
|
|
3188
Autohome
ATHM
$2.48B
| $610K | ﹤0.01% |
+28,700
| New | +$622K |
2026 Q3
0 quarters
|
|
3189
NIQ Global Intelligence PLC
NIQ
$5.67B
| $610K | ﹤0.01% |
35,849
-230,565
| -87% | -$3.46M |
2025 Q3
4 quarters
|
|
3190
Sprout Social
SPT
$678M
| $609K | ﹤0.01% |
62,350
+1,876
| +3% | +$17.9K |
2026 Q2
1 quarter
|
|
3191
Metropolitan Bank Holding Corp
MCB
$1.19B
| $609K | ﹤0.01% |
6,991
-1,093
| -14% | -$101K |
2025 Q3
4 quarters
|
|
3192
PUT
DTE Energy
DTE
$29B
| $609K | ﹤0.01% |
+5,000
| New | +$694K |
2026 Q3
0 quarters
|
|
3193
FS Bancorp
FSBW
$340M
| $609K | ﹤0.01% |
14,058
+289
| +2% | +$12.5K |
2025 Q4
3 quarters
|
|
3194
CALL
Lincoln Electric
LECO
$15.4B
| $609K | ﹤0.01% |
+2,300
| New | +$613K |
2026 Q3
0 quarters
|
|
3195
CALL
NextDecade
NEXT
$1.75B
| $608K | ﹤0.01% |
95,800
+54,000
| +129% | +$387K |
2025 Q4
3 quarters
|
|
3196
Tapestry
TPR
$26.1B
| $606K | ﹤0.01% |
5,269
-4,340
| -45% | -$580K |
2023 Q4
11 quarters
|
|
3197
PUT
Entergy
ETR
$53.5B
| $605K | ﹤0.01% |
6,100
-5,700
| -48% | -$615K |
2026 Q2
1 quarter
|
|
3198
Hingham Institution for Saving
HIFS
$662M
| $605K | ﹤0.01% |
2,142
+848
| +66% | +$253K |
2026 Q2
1 quarter
|
|
3199
Aura Biosciences
AURA
$740M
| $605K | ﹤0.01% |
+96,342
| New | +$689K |
2026 Q3
0 quarters
|
|
3200
NRC Health Common Stock
NRC
$565M
| $605K | ﹤0.01% |
28,533
-8,468
| -23% | -$180K |
2025 Q4
3 quarters
|
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.